The influenza sector fluctuated weakly, and Te Yi Pharmaceutical hit the lower limit.

The anti-influenza sector's fluctuation weakens, with Teiyi Pharmaceutical hitting the limit down, Jiaying Pharmaceutical previously hitting the limit down, Zhongsheng Pharmaceutical, Dana Biology, Asia-Pacific Pharmaceutical, Panlong Pharmaceutical, and Tailong Pharmaceutical falling in line.